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Correlations between diabetes knowledge and ADDQoL, EQ-5D
and SF-6D scores were 0.26, 0.30 and 0.21 respectively.
Although none of the independent variables was associated 
signiﬁcantly with HRQoL scores in any MLR model (p > 0.05),
a trend of association was nevertheless observed. CONCLU-
SIONS: Our results showed diabetes knowledge to be weakly
correlated with both diabetes-speciﬁc and generic health related
quality of life. In addition, diabetes knowledge may be positively
associated with diabetes-speciﬁc HRQoL but further studies 
utilizing larger sample size are required to conﬁrm this 
observation.
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OBJECTIVES: Conditions comorbid with diabetes could have
an impact on clinical outcomes and quality of life. This study
examines relationships between the SF12, treatment options,
clinical outcomes, and comorbid depression in Type-2 diabetes
patients. METHODS: Participants with Type-2 diabetes in a
population study at university hospital outpatient clinics com-
pleted the SF12 and the CES-D scale (16 or higher indicates
depression). Patient reported data (including self-report of
comorbidities) was collected by mail out questionnaire, and
merged with a retrospective collection of patient clinical and 
utilization data via patient’s EMR. A cover letter signed by the
patient’s provider was sent with the questionnaire. RESULTS:
Usable response rate was 47.2% (n = 412); 56.8% respondents
were female, 64.1% in 40–69 age range, 94.2% Caucasian,
47.1% on oral medications only, 32.3% oral medications and
insulin, and 13.4% on insulin only. There was no signiﬁcant dif-
ference in mean A1C between insulin only group and oral med-
ications and insulin group. SF12 Physical Component Summary
(PCS) scores were signiﬁcantly higher in the oral medications
group than in the oral medications and insulin users group (p <
0.05), while no signiﬁcant differences were found in SF12 Mental
Component Summary (MCS) scores. Both PCS and MCS scores
signiﬁcantly correlated with number of self-reported comorbidi-
ties and complications (p < 0.01), and were both also signiﬁ-
cantly lower in the depressed group (p < 0.05). There were also
no signiﬁcant differences in depression among the various treat-
ment groups, although mean CESD score was greater than 
16 for each group. Although no signiﬁcant difference in A1C
between depressed and non-depressed groups was found,
depressed patients had a signiﬁcantly greater number of compli-
cations (p < 0.05). CONCLUSIONS: A generic measure like the
SF12 was able to detect variations in quality of life among dia-
betes patients on different treatment options, and with different
level of self-reported complications and comorbidities.
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OBJECTIVE: To assess preference and willingness-to-pay (WTP)
for inhaled insulin (INI). Various INI technologies are under
development and will be marketed soon. However, they are likely
to be substantially more expensive than subcutaneous insulin
(SCI). We previously reported Ontario diabetic patients’ WTP
for INI. Whether general public accept this increased cost and
the value that they would give to this new technology are 
important questions which can be addressed through Contingent 
Valuation (CV). METHODS: A previously validated self-
administered questionnaire was mailed to 250 Greater Toronto
Area (GTA) households, randomly chosen based on postal codes.
One hundred questionnaires were returned, of which 85 were
complete and used for analysis. Standardized information about
diabetes and its prevalence in Ontario, INI and SCI, was pro-
vided in an informative letter based on published data. Respon-
dents’ preference for INI, and socio-economic and health data
were collected. Respondent’s WTP was elicited using “payment
scale” method. The payment vehicle was out-of-pocket.
RESULTS: Respondents were 50.8 ± 12.2 years old, 45 were
male. Signiﬁcantly more respondents preferred INI (n = 81) over
SCI (n = 4, df = 1, ∏2 = 69.75, P < 0.001). The mean monthly
WTP for INI was $68.59 ± $44.65, signiﬁcantly more than the
current average SCI cost of $50 in Ontario (tdf95 = 3.83,
CI95%:$58.87–$78.07). However, signiﬁcantly less than dia-
betic patients WTP for INI ($153.70 ± $99.90, P < 0.001) that
we previously reported. WTP for INI in subgroup of respondents
with diabetes was $98.52 ± $48.57, signiﬁcantly more than 
the WTP of general public (Mann-WhitneyU = 365.0, Z = -4.0,
P < 0.001). Multiple regression analysis showed a strong associ-
ation between respondents’ income and having diabetic (self or
family member) and their WTP for INI (F = 32.07, df(4&80), P
< 0.001). Major factors inﬂuencing the respondents preference
and WTP were convenience and income. CONCLUSION: GTA
general public prefer INI over SCI and will pay signiﬁcantly more
per month than the current SCI cost. The results could be used
in a cost-beneﬁt analysis and for future policy making.
EAR
PER1
EVALUATION OF AN OTITIS MEDIA EDUCATION
INTERVENTION IN AN INTEGRATED DELIVERY SYSTEM
Beaton SJ1, Gunter MJ1, Paez KA1, Chilton L2, Dougherty D3
1Lovelace Clinic Foundation, Albuquerque, NM, USA; 2Lovelace 
Sandia Health System, Albuquerque, NM, USA; 3Agency for
Healthcare Research and Quality (AHRQ), Rockville, MD, USA
OBJECTIVES: The purpose of this study was to evaluate the
effectiveness of a program aimed at changing physician behav-
ior in accordance with evidence-based guidelines. The program
goals were to: improve accuracy of otitis diagnosis; prescribe
antibiotics less frequently; and prescribe analgesic drops more
frequently. We examined outcome differences for patients treated
by intervention clinic providers vs. by control clinic providers.
METHODS: Ten primary care clinics in a southwestern inte-
grated delivery system were organized into matched pairs and
assigned to either control status (mailed guidelines only) or inter-
vention status (provider exposure to formal education, guideline
tools, reinforcement messages, and feedback). The impact of the
intervention on providers who participated in the intervention
was measured using claims data for patients diagnosed with
otitis media and a post-intervention provider survey. The
outcome measures were: percentage of episodes with a primary
diagnosis of either acute otitis media (AOM), or otitis media
with effusion (OME) and/or otalgia, rate of antibiotic ﬁlls for
the two diagnosis categories; and analgesic drop ﬁll rate.
RESULTS: Claims data analysis showed signiﬁcant improvement
for intervention clinic providers over control group providers 
in decreased diagnosis of AOM (94.0% pre- vs. 91.2% post-
intervention, p = 0.0231) and increased analgesic drop ﬁlls
(7.6% pre- vs. 10.4% post-intervention for AOM, 2.4% to
11.5% for OME/otalgia, p = 0.0250), but no statistical signiﬁ-
